Key result
LDL-C levels outperform LDLR mutation type in predicting cardiovascular event-free survival in FH.
Why the study?
Does the type of LDLR mutation influence the age at first cardiovascular event in patients with familial hypercholesterolaemia?
Cohort (n=862)
Does the type of LDLR mutation influence the age at first cardiovascular event in patients with familial hypercholesterolaemia?
In patients with familial hypercholesterolaemia, absolute LDL-C levels are a more important determinant of event-free survival than the specific underlying LDLR mutation type.
AIMS: To investigate the influence of different LDL-receptor (LDLR) gene mutations on age at first cardiovascular event in familial hypercholesterolaemia (FH) patients. METHODS AND RESULTS: Dutch FH patients (n = 862) with known LDLR mutations from a retrospective cohort study were included. A gamma frailty Cox model was used. An event was defined as the first cardiovascular event. Gender, hypertension, smoking, diabetes, HDL cholesterol, LDL cholesterol (LDL-C), or triglycerides were included as covariates. Furthermore, the effect of LDLR mutation type on LDL and HDL cholesterol levels was investigated using mixed effects models, including gender, smoking, body mass index, and age at time of lipid measurement as covariates. A total of 86 different LDLR mutations were present in this cohort. Twenty-two percent of patients experienced an event (median age: 47.1 year; range: 25.6-85.8 years). The effect of LDLR mutation type on event-free survival is only significant in the models without LDL-C levels. Also, LDLR mutation type was significantly associated with LDL-C levels (P = 0.007), but not with HDL cholesterol levels (P = 0.12). CONCLUSION: In the present study, LDL-C levels are a more important risk factor of event-free survival than the type of LDLR mutation.
No takes yet. Share an insight, caveat, or question.
Souverein et al. (2006) conducted a cohort in familial hypercholesterolaemia (n=862). LDLR mutation type was evaluated on first cardiovascular event. Among patients with familial hypercholesterolaemia, 22% experienced a cardiovascular event, and LDL-C levels were a more important risk factor for event-free survival than LDLR mutation type.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: